Multi-specialty Physician Preferences and Perceptions in Treatment and Management of Polycystic Ovary Syndrome in China: Survey and Discrete Choice Experiment
The decision making by physicians on PCOS treatment largely relies on the presence of clinical hyperandrogenism across all three specialties, indicating the significance of hyperandrogenism assessment in clinical practice, and the role of biochemical hyperandrogenism in PCOS treatment may require further elucidation in future clinical guidelines. Furthermore, the results emphasize the urgent need to bridge the gap between the clinical practice and guidance recommendations for the diagnosis and treatment of PCOS in China.
Authors
- Haijiao Liu (ORCID: https://orcid.org/0000-0001-8276-7077)
- Hui‐Chuan Sun (ORCID: https://orcid.org/0000-0003-3761-7058)
- Jian Ming (ORCID: https://orcid.org/0000-0002-4987-6391)
- Wei Chen (ORCID: https://orcid.org/0000-0003-4560-4599)
- Zhe Xu (ORCID: https://orcid.org/0000-0003-1519-6707)
- Yingyao Chen (ORCID: https://orcid.org/0000-0002-3470-0748)
- Qinjie Tian (ORCID: https://orcid.org/0000-0002-7461-4203)
- Yijing Li (ORCID: https://orcid.org/0000-0002-3779-1016)
- Zhuowei Gu (ORCID: https://orcid.org/0000-0002-7310-5669)
Institutions
- Bayer (United States) (US)
- National Health and Family Planning Commission (CN)
- Renji Hospital (CN)
- Shanghai Medical Information Center (CN)
- Ta Solutions (China) (CN)
Publication Details
- Journal
- Advances in Therapy
- Published
- 2025-08-08
- DOI
- https://doi.org/10.1007/s12325-025-03311-7
- Primary Topic
- Ovarian function and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fudan University